Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:421-425

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goto, A.
Right arrow Articles by Omata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goto, A.
Right arrow Articles by Omata, M.

(Hypertension. 1996;28:421-425.)
© 1996 American Heart Association, Inc.


Articles

Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome

Atsuo Goto; Kaoru Yamada; Hisanori Hazama; Yoshio Uehara; Keiichiro Atarashi; Yasunobu Hirata; Kenjiro Kimura; Masao Omata

the Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, and Department of Human Dry Dock, Sanraku Hospital (K.Y.), Tokyo, Japan.

Molecular mechanisms related to sodium retention have been implicated in the pathogenesis of hypertension. It is unclear how sodium retention leads to a rise in blood pressure, but ouabainlike compound may act as a final common pathway in sodium-induced hypertension. In ectopic corticotropin syndrome, hypertension has been attributed to cortisol inactivation overload, giving rise to mineralocorticoid-type hypertension. We sequentially measured plasma and urinary levels of ouabainlike compound over 2 months to evaluate its role in the hypertensive mechanisms in a 64-year-old man with this syndrome caused by lung cancer. His data included hypokalemia and increased cortisol concentrations, corticotropin levels, and urinary 17-hydroxycorticosteroid excretion. Plasma renin activity was suppressed. Plasma and urinary levels of ouabainlike compound were markedly increased concomitantly with high blood pressure. The maximum plasma level was 40-fold the normal range of the subject. After chemotherapy, ouabainlike compound levels gradually decreased in parallel with the decline in blood pressure and rise in potassium concentration. A correlation was observed between plasma and urinary levels of ouabainlike compound (P<.05). Plasma and urinary levels of ouabainlike compound correlated with systolic (P<.01) and diastolic (P<.05) pressures, respectively. The peak of ouabainlike compound in plasma and urine coincided with that of authentic ouabain on high-performance liquid chromatography. Ouabainlike compound derived from urine inhibited [3H]ouabain binding to human erythrocytes. These findings suggest that ouabainlike compound with biological activity could partly account for hypertension in ectopic corticotropin syndrome.


Key Words: hormones • adrenocorticotropic hormone • Na+,K+-transporting ATPase • sodium-potassium pump • blood pressure • potassium • sodium




This article has been cited by other articles:


Home page
HypertensionHome page
M. P. Blaustein, J. Zhang, L. Chen, H. Song, H. Raina, S. P. Kinsey, M. Izuka, T. Iwamoto, M. I. Kotlikoff, J. B. Lingrel, et al.
The Pump, the Exchanger, and Endogenous Ouabain: Signaling Mechanisms That Link Salt Retention to Hypertension
Hypertension, February 1, 2009; 53(2): 291 - 298.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Ihenetu, H. M. Qazzaz, F. Crespo, R. Fernandez-Botran, and R. Valdes Jr
Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia
Clin. Chem., July 1, 2007; 53(7): 1315 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton
How does salt retention raise blood pressure?
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Dostanic-Larson, J. N. Lorenz, J. W. Van Huysse, J. C. Neumann, A. E. Moseley, and J. B Lingrel
Physiological role of the {alpha}1- and {alpha}2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R524 - R528.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. H. Kaplan
The sodium pump and hypertension: A physiological role for the cardiac glycoside binding site of the Na,K-ATPase
PNAS, November 1, 2005; 102(44): 15723 - 15724.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Dostanic-Larson, J. W. Van Huysse, J. N. Lorenz, and J. B Lingrel
From The Cover: The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation
PNAS, November 1, 2005; 102(44): 15845 - 15850.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. R. Shah, J. Laredo, B. P. Hamilton, and J. M. Hamlyn
Different Signaling Pathways Mediate Stimulated Secretions Of Endogenous Ouabain and Aldosterone From Bovine Adrenocortical Cells
Hypertension, January 1, 1998; 31(1): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ferrandi, P. Manunta, S. Balzan, J. M. Hamlyn, G. Bianchi, and P. Ferrari
Ouabain-like Factor Quantification in Mammalian Tissues and Plasma : Comparison of Two Independent Assays
Hypertension, October 1, 1997; 30(4): 886 - 896.
[Abstract] [Full Text]